Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to Press Play with Madeleine Brand

Press Play with Madeleine Brand

Cuba is close to producing a COVID vaccine and hopes to draw tourists with it

Scientists in Cuba say they’re close to developing a coronavirus vaccine of their own. It’s called “ Sovereign 2 ,” and it’s in its final trial stage. If successful, Cuba says it may make it available to tourists.

  • rss
  • Share
By Madeleine Brand • Feb 23, 2021 • 7m Listen

Scientists in Cuba say they’re close to developing a coronavirus vaccine of their own. It’s called “Sovereign 2,” and it’s in its final trial stage. If successful, Cuba says it may make it available to tourists. But with an economy battered by decades of sanctions from the U.S., will Cuba be able to pull this off?

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Madeleine Brand

    Host, 'Press Play'

  • KCRW placeholder

    Sarah Sweeney

    Vice President of Talk Programming, KCRW

  • KCRW placeholder

    Angie Perrin

    Producer, Press Play

  • KCRW placeholder

    Michell Eloy

    Line Editor, Press Play

  • KCRW placeholder

    Natalie Kitroeff

    New York Times correspondent for Mexico, Central America and the Caribbean

    NewsInternationalCoronavirusHealth & WellnessScience
Back to Press Play with Madeleine Brand